Caldwell Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.72M Buy
10,658
+2,204
+26% +$367K 0.14% 125
2026
Q2
$1.6M Buy
8,454
+1,836
+28% +$345K 0.13% 133
2026
Q1
$1.31M Buy
6,618
+1,108
+20% +$214K 0.12% 142
2025
Q4
$1.01M Buy
5,510
+5,336
+3,067% +$936K 0.09% 164
2025
Q3
$26.6K Hold
174
– – ﹤0.01% 541
2025
Q2
$24.2K Hold
174
– – ﹤0.01% 543
2025
Q1
$25.6K Buy
174
+133
+324% +$19.2K ﹤0.01% 531
2024
Q4
$5.31K Hold
41
– – ﹤0.01% 649
2024
Q3
$6.31K Buy
+41
New +$6.62K ﹤0.01% 641
2024
Q2
– Sell
-143
Closed -$19.3K – 693
2024
Q1
$19.3K Sell
143
-42
-23% -$5.56K ﹤0.01% 556
2023
Q4
$24.9K Buy
185
+42
+29% +$5.46K ﹤0.01% 522
2023
Q3
$19.3K Hold
143
– – ﹤0.01% 547
2023
Q2
$20.4K Hold
143
– – ﹤0.01% 552
2023
Q1
$19.8K Hold
143
– – ﹤0.01% 552
2022
Q4
$19.3K Buy
+143
New +$17.9K ﹤0.01% 543
2021
Q3
– Sell
-24
Closed -$2.82K – 734
2021
Q2
$2.82K Hold
24
– – ﹤0.01% 705
2021
Q1
$2.34K Hold
24
– – ﹤0.01% 696
2020
Q4
$2.35K Hold
24
– – ﹤0.01% 697
2020
Q3
$2.58K Sell
24
-247
-91% -$27.5K ﹤0.01% 695
2020
Q2
$28.6K Sell
271
-1
-0.4% -$103 ﹤0.01% 496
2020
Q1
$24.2K Hold
272
– – ﹤0.01% 527
2019
Q4
$27.1K Buy
+272
New +$25.6K ﹤0.01% 548

Other funds holding AZN

Caldwell Trust's AZN Position: Q3 2026 in Review

Caldwell Trust increased its AstraZeneca (AZN) stake by 26% in Q3 2026, buying an estimated $367K and bringing the position to 10,658 shares worth $1.72M. The position accounts for 0.14% of the portfolio, ranked #125.

Caldwell Trust first reported a position in AZN in Q4 2019 and has held it in 22 quarters since. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Caldwell Trust held 10,658 shares of AstraZeneca worth $1.72M as of Q3 2026.
  • Caldwell Trust bought 2,204 AstraZeneca shares in Q3 2026, an estimated $367K.
  • AstraZeneca made up 0.14% of Caldwell Trust's portfolio in Q3 2026, its #125 holding.
  • Caldwell Trust first reported a position in AstraZeneca in Q4 2019 and has held it in 22 quarters since.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Caldwell Trust's 13F filing for Q3 2026, filed 30 Oct 2026.